Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'gsk 3 inhibitor 1'

Search results for: 'gsk 3 inhibitor 1'

Items 171-180 of 358

Page
per page
  1. Tasquinimod
    A3860 Tasquinimod
    Summary: Antiangiogenic and antineoplastic agent
      insoluble in H2O; ≥20.32 mg/mL
  2. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  3. Baricitinib (LY3009104, INCB028050)
    A4141 Baricitinib (LY3009104, INCB028050)
     2 Citation
    Summary: JAK1/JAK2 inhibitor,selective orally bioavailable
      insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL
  4. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL
  5. UNC1215
    A3901 UNC1215
     1 Citation
    Target: L3MBTL
    Summary: Chemical probe for the methyllysine (Kme)
      ≥26.05 mg/mL
  6. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor,highly potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
  7. TCS 401
    A4545 TCS 401
    Summary: Selective PTP1B inhibitor
      Soluble in DMSO
  8. MK-4827 hydrochloride
    B1163 MK-4827 hydrochloride
    Summary: PARP1/PARP2 inhibitor
      Soluble in DMSO
  9. MK-4827 tosylate
    B1164 MK-4827 tosylate
    Summary: PARP1/PARP2 inhibitor
      Soluble in DMSO
  10. Tautomycetin
    B7009 Tautomycetin
    Summary: A novel and specific protein phosphatase 1 (PP1) inhibitor
      Soluble in DMSO (supplied pre-dissolved in DMSO

Items 171-180 of 358

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 34item
  2. Aurora Kinase 30item
  3. DNA Methyltransferase 6item
  4. HDAC 60item
  5. Histone Acetyltransferases 17item
  6. Histone Demethylases 24item
  7. Histone Methyltransferase 42item
  8. HIF 11item
  9. JAK 41item
  10. MBT Domains 1 item
  11. PARP 31item
  12. Pim 8item
  13. Protein Ser/Thr Phosphatases 31item
  14. RNA Polymerase 3item
  15. Sirtuin 15item
  16. Sphingosine Kinase-2 1 item
  17. Polycomb repressive complex 1 item
  18. SUMOylation 2item
  19. PAD 1 item
Specificity
  1. Selective 106item
Reversibility
  1. Reversible 7item
  2. Irreversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 34item
  3. PI3K 1 item
  4. Aurora Kinases 21item
  5. MDM2 1 item
  6. EZH2 3item
  7. Bromodomains 8item
  8. FLT3 5item
  9. PLK 1 item
  10. VEGFR 3item
  11. RET 1 item
  12. Hydrolase 1 item
  13. MEK 1 item
  14. DOT1L 3item
  15. FGFR 2item
  16. Nrf2 1 item
  17. Pim 3item
  18. Sir2-like Family Deacetylases (Sirtuins) 3item
  19. PP1 1 item
  20. PP2A 1 item
  21. Src 5item
  22. Trk Receptors 1 item
  23. STAT 2item
  24. EGFR 2item
  25. Hypoxia Inducible Factors (HIFs) 2item
  26. Tankyrases 1 item
  27. JAK 20item
  28. p300 1 item
  29. Syk 1 item
  30. EZH1 1 item
  31. TNKS 1 item
  32. Topoisomerases 1 item
  33. ErbB 1 item
  34. DNA Methyltransferases 4item
  35. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  36. SMYD2 1 item
  37. CREBBP 2item
  38. EP300 2item
  39. LRRK2 1 item
  40. PARP 8item
  41. ALK 1 item
  42. Bromodomain and Extra-Terminal motif (BET) 1 item
  43. phosphatases 1 item
  44. NAT10 1 item
  45. G9a 2item
  46. Hck 1 item
  47. SETD7 1 item
  48. Histone Demethylases 1 item
  49. MNK 1 item
  50. AChE 1 item
  51. Catechol O-Methyltransferase (COMT) 1 item
  52. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  53. Protein Arginine Methyltransferases 1 item
  54. Cytidine deaminases 1 item
  55. PP4 1 item
  56. c-RET 1 item
  57. VEGFR3/FLT4 1 item
  58. NTRK1/TRKA 1 item
  59. CSF-1R/c-Fms 1 item
  60. PTP 1 item
  61. Protein polybromo-1 1 item
  62. SMARCA4 1 item
  63. SMARCA2 1 item
  64. p53 2item
  65. HDAC 2item
  66. KDM 2item
  67. Histone Acetyltransferases (HATs) 2item
  68. Trx 1 item
  69. HIF-PH 1 item
  70. L3MBTL 1 item
  71. TYK2 2item
  72. MUSK 1 item
  73. MAP3K 1 item
  74. Lck 1 item
  75. p21 1 item
  76. 5-HT 1 item
  77. PHF 1 item
  78. FGR 1 item
  79. YES 1 item
  80. Fyn 1 item
  81. ARG 1 item
  82. LSD 1 item
  83. PRMT 1 item
  84. GLP 1 item
  85. SK 1 item
  86. Sirtuin 1 item
Reported Experiments
  1. Animal Experiments 120item
  2. Cell Experiments 100item
Related Disease
  1. Acute Myelogenous Leukemia 2item
  2. Acute Myeloid Leukemia 9item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Breast Cancer 19item
  6. Cancer 85item
  7. Castration-resistant Prostate Cancer 1 item
  8. Cervical Cancer 2item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 11item
  11. Colon Carcinoma 1 item
  12. Colorectal Cancer 5item
  13. Diabetes 1 item
  14. Diffuse Large B-cell Lymphoma 1 item
  15. Dyskinesia 1 item
  16. Epilepsy 1 item
  17. Friedreich's Ataxia 1 item
  18. Glioblastoma 2item
  19. Glioma 2item
  20. Hepatic Cancer 1 item
  21. Hepatocellular Carcinoma 1 item
  22. HIV 2item
  23. HIV Infections 2item
  24. Immunological Diseases 1 item
  25. Inflammatory Bowel Disease 1 item
  26. Inflammatory Diseases 3item
  27. Leukemia 7item
  28. Lung Cancer 6item
  29. Lymphoma 6item
  30. Melanoma 5item
  31. Mixed Lineage Leukemia 3item
  32. Multiple Myeloma 5item
  33. Myelofibrosis 1 item
  34. Myeloma 1 item
  35. Neuroblastoma 2item
  36. Neuronal Protection 1 item
  37. Non-small Cell Lung Cancer 5item
  38. Ovarian Cancer 5item
  39. Pancreatic Cancer 4item
  40. Prostate Cancer 12item
  41. Psoriasis 1 item
  42. Renal Cancer 1 item
  43. Renal Cell Carcinoma 2item
  44. Rheumatoid Arthritis 3item
  45. Thyroid Cancer 1 item